The HVAD is now a Medtronic product. How will HeartWare’s left ventricular assist device (LVAD) business change now that it is part of Medtronic’s massive product portfolio?
Executives at the medtech giant recently gave a glimpse of how HVAD will fit into its broad cardiovascular offerings and what Medtronic’s R&D capabilities can bring to LVAD technology.
Speaking on Medtronics’ latest earnings call, chairman and CEO Omar Ishrak said, “We’re pleased to now significantly broaden our range of therapeutic options for heart failure patients with the addition of HeartWare and we expect it to add meaningful revenue growth to CVG [Cardiac & Vascular Group] throughout the balance of the fiscal year and beyond,” according to the Seeking Alpha call transcript.
